HealthTech Habitual has raised a £1m funding round with backing from Lexham Partners.
The London company is dedicated to empowering sustainable weight loss and long-lasting habit change.
Existing board member Professor Sneh Khemka CBE has also been named chairman.
With more than half a million Brits being prescribed Wegovy and Mounjaro, the weight loss market is already huge and set to grow further.
Providing holistic weight loss solutions including GLP-1 medication, meal replacement shakes and soups and personalised support, Habitual aims to use the funding to expand its pipeline of holistic ancillary products and services to cater to individuals on their weight loss journeys.
Originally from California, founder Napala Pratini initially pursued a career in medicine but later shifted her focus to technology and entrepreneurship.
After working in various FinTech companies and as a growth and strategy consultant, she moved to the UK to study for an MBA at Oxford University. While working at a research organisation focused on diabetes reversal, she recognised the potential of holistic treatment and habit change to address chronic health conditions.
This led her to co-found Habitual with the aim of scaling these findings and providing solutions to help people not only reverse type 2 diabetes and other weight-related issues but also sustain healthy habits.
“With over half a million people in the UK now using GLP-1 medications and the NHS funding weight loss programmes for patients with type 2 diabetes, it’s clear that we are in a transformational time for metabolic health,” said CEO Pratini.
“This funding allows us to accelerate the development of our holistic, science-backed solutions that go beyond just medication – ensuring that people have the long-term support they need to sustain real, lasting health improvements.”
Professor Khemka said: “I am proud to be joining Habitual as chairman at this pivotal moment. The company is helping thousands of people to lose weight in a responsible and sustained manner, and supporting the NHS to reverse type 2 diabetes in those most in need.
“After many years of an obesity crisis, we are now seeing the tide turning, and with the money raised we can help even more people up and down the country.”